RP
ABEO icon

Riverwater Partners’s Abeona Therapeutics ABEO Stock Holding History

Riverwater Partners’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.4K Sell
19,066
-309
-2% -$1.54K 0.03% 211
2025
Q4 		$102K Buy
19,375
+3,518
+22% +$17.7K 0.04% 209
2025
Q3 		$83.7K Buy
15,857
+4,963
+46% +$31.5K 0.03% 215
2025
Q2 		$61.9K Buy
+10,894
New +$62K 0.03% 201

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Riverwater Partners's ABEO Position: Q1 2026 in Review

Riverwater Partners reduced its Abeona Therapeutics (ABEO) stake by 1.6% in Q1 2026, selling an estimated $1.54K and leaving 19,066 shares worth $85.4K. The position accounts for 0.03% of the portfolio, ranked #211.

Riverwater Partners first reported a position in ABEO in Q2 2025 and has held it in 4 quarters since. The position peaked at $102K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Riverwater Partners held 19,066 shares of Abeona Therapeutics worth $85.4K as of Q1 2026.
  • Riverwater Partners sold 309 Abeona Therapeutics shares in Q1 2026, an estimated $1.54K.
  • Abeona Therapeutics made up 0.03% of Riverwater Partners's portfolio in Q1 2026, its #211 holding.
  • Riverwater Partners first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Riverwater Partners's Abeona Therapeutics position peaked at $102K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Riverwater Partners's 13F filing for Q1 2026, filed 8 May 2026.